GGrantIndex
← Leaderboards

G M Anantharamaiah

University Of Alabama At Birmingham

$8,833,772
Attributed
$10,105,597
Total exposure
8
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $970.2K · FY200519
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19

Funding mix

By agency

NIH$10,105,597 · 8

By mechanism

R01$5,985,737 · 5
P01$4,119,860 · 3

Top collaborators

Most similar at University Of Alabama At Birmingham

Same institution · by research overlap

Others in their field

Top investigators on “Cholesterol

Research focus

CholesterolLipoproteinsPeptidesInflammatoryHigh Density LipoproteinsMimeticsParticleMouse ModelPropertyAtherosclerosisIn VitroPlasmaAnti-InflammatoryMediatingMacrophageAnti-Inflammatory AgentsProteinsApolipoprotein A-ISynthetic PeptidePeptide AnalogLeadReverse Cholesterol TransportCellsLipids

Grant awards (38)

HDL and Cellular Repair Mechanisms$330,750
R01 · FY2019 · DK
HDL and Cellular Repair Mechanisms$330,750
R01 · FY2018 · DK
Cellular Lipids and Leukocyte Function$290,325
R01 · FY2018 · GM
HDL and Cellular Repair Mechanisms$330,750
R01 · FY2017 · DK
Cellular Lipids and Leukocyte Function$290,325
R01 · FY2017 · GM
HDL and Cellular Repair Mechanisms$330,750
R01 · FY2016 · DK
Cellular Lipids and Leukocyte Function$290,325
R01 · FY2016 · GM
Cellular Lipids and Leukocyte Function$59,350
R01 · FY2016 · GM
Cellular Lipids and Leukocyte Function$290,325
R01 · FY2015 · GM
Peptide Synthesis and Purification Core Facility$239,586
P01 · FY2012 · HL · contact PI
Modulators of HDL Structure-Function$239,586
P01 · FY2012 · HL · contact PI
Apo E mimetics reduce cholesterol and improve HDL function$412,969
R01 · FY2011 · HL · contact PI
Peptide Synthesis and Purification Core Facility$239,586
P01 · FY2011 · HL · contact PI
Modulators of HDL Structure-Function$239,586
P01 · FY2011 · HL · contact PI
Modulators of HDL Structure-Function$433,550
P01 · FY2010 · HL · contact PI
Apo E mimetics reduce cholesterol and improve HDL function$417,140
R01 · FY2010 · HL · contact PI
Peptide Synthesis and Purification Core Facility$119,480
P01 · FY2010 · HL · contact PI
Modulators of HDL Structure-Function$433,550
P01 · FY2009 · HL · contact PI
Apo E mimetics reduce cholesterol and improve HDL function$413,257
R01 · FY2009 · HL · contact PI
Peptide Synthesis and Purification Core Facility$119,480
P01 · FY2009 · HL · contact PI
Modulators of HDL Structure-Function$433,550
P01 · FY2008 · HL · contact PI
Apo E mimetics reduce cholesterol and improve HDL function$401,221
R01 · FY2008 · HL · contact PI
Peptide Synthesis and Purification Core Facility$119,480
P01 · FY2008 · HL · contact PI
Modulators of HDL structure-function$362,500
R01 · FY2007 · HL · contact PI
Core--Peptide synthesis and protein purification$291,326
P01 · FY2006 · HL · contact PI
Antiatherogenic amphipathic peptides: structure/function$291,326
P01 · FY2006 · HL · contact PI
Antiatherogenic amphipathic peptides: structure/function$283,687
P01 · FY2005 · HL
Core--Peptide synthesis and protein purification$283,687
P01 · FY2005 · HL
Enhanced Hepatic Lipoprotein Uptake and Atherogenesis$358,750
R01 · FY2004 · HL
Enhanced Hepatic Lipoprotein Uptake and Atherogenesis$358,750
R01 · FY2003 · HL
Enhanced Hepatic Lipoprotein Uptake and Atherogenesis$358,750
R01 · FY2002 · HL
Core--Peptide synthesis and protein purification$0
P01 · FY2002 · HL
Antiatherogenic amphipathic peptides: structure/function$0
P01 · FY2002 · HL
Enhanced Hepatic Lipoprotein Uptake and Atherogenesis$358,750
R01 · FY2001 · HL
CORE--PEPTIDE SYTHESIS$0
P01 · FY2001 · HL
DETERMINANTS OF ATHEROSCLEROSIS PROTECTION$0
P01 · FY2001 · HL
CORE--PEPTIDE SYTHESIS$176,200
P01 · FY2000 · HL
DETERMINANTS OF ATHEROSCLEROSIS PROTECTION$176,200
P01 · FY2000 · HL